title: Inhibition of EGFR signaling: all mutations are not created equal.
authors.affiliation: Hamon Center for Therapeutic Oncology Research and in the Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America. adi.gazdar@utsouthwestern.edu
authors.forename: Adi F
authors.initials: AF
authors.lastname: Gazdar
authors.forename: John D
authors.initials: JD
authors.lastname: Minna
mesh_terms: D066246:ErbB Receptors / Q000235:genetics* / Q000502:physiology; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000503:physiopathology; D011505:Protein-Tyrosine Kinases / Q000235:genetics* / Q000378:metabolism; D015398:Signal Transduction
chemical_list: D066246:ErbB Receptors; D011505:Protein-Tyrosine Kinases